Khiron Life Sciences Corp.

Recent News

  • Khiron Life Sciences Agrees to $500,000 Secured Deposit

    Toronto, Ontario--(Newsfile Corp. - June 5, 2023) -  Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF) ("Khiron" or the "Company") announced today that the Company has agreed to a $500,000 non-interesting bearing refundable deposit from 2518542 Alberta Ltd. ("251"), a company controlled by Avonlea-Drewry Holdings Inc., to be secured by all of Khiron's present and after-acquired property pursuant to a general security agreement and a pledge of Khiron's shares in its subsidiaries, Pharmadrug Production GmbH and Zerenia Clinics UK Limited...

    2023-06-05 7:30 AM EDT
  • Medical First: Germany Strengthens Reimbursement of Medical Cannabis

    On 16 March 2023, after five years of observational data collection the German Federal Joint Committee (G-BA) decided on the future regulations that will govern the prescription of medical cannabis as a benefit of the statutory health insuranceAfter several months of discussions and thoroughly analyzing the data, the G-BA passed regulations that ensure patient care with medical cannabis and coverage by statutory health insuranceGermany is the largest and fastest growing medical cannabis market in Europe which Khiron directly supplies via...

    2023-04-25 8:30 AM EDT
  • Khiron Completes First Phase of Business Optimization

    First phase of optimization was focused on streamlining Colombian operations, resulting in a moving forward annualized cost reduction of CAD 5.0 million, representing overall cost savings of more than 45% compared to 20221.Khiron has completed the wind down of its Colombian cultivation and extraction activities, to focus on its clinics business and its high-margin B2C medical cannabis model in Colombia.Similar to the Company’s European production model, Khiron Colombia will outsource the production of Khiron-branded medical cannabis products to a reputable...

    2023-04-20 4:41 PM EDT
  • Khiron Life Sciences Announces Closing of Marketed Offering Including Full Exercise of Over-Allotment Option

    Toronto, Ontario--(Newsfile Corp. - April 4, 2023) - Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF) ("Khiron" or the "Company") is pleased to announce that it has closed today its previously announced marketed public offering of units of the Company ("Units"), including the exercise in full of the over-allotment option (the "Offering").A total of 13,800,000 Units were sold at a price of $0.05 per Unit (the "Offering Price") for aggregate gross proceeds of $690,000. The Offering was led by Canaccord...

    2023-04-04 9:30 AM EDT
  • Khiron Closes Additional Loan with Investment-Grade Bank

    The term loan, provided by one of Colombia's largest and traditional private banks, provides immediate access to liquidity, and further strengthens Khiron's credibility with long-established banking institutions.Toronto, Ontario--(Newsfile Corp. - February 16, 2023) - Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF) (WKN: A2JMZC) ("Khiron" or the "Company") , announces that its wholly owned subsidiary Zerenia™ Colombia has closed a credit facility of around CAD 700,000[1] with one of Colombia's largest private banks. This loan is further non-dilutive capital in...

    2023-02-16 8:57 AM EST
  • Khiron Closes Revolving Credit Facility with Financing Company in Colombia

    Toronto, Ontario--(Newsfile Corp. - February 14, 2023) - Khiron Life Sciences Corp. (TSXV: KHRN) (OTCQB: KHRNF) (FSE: A2JMZC) ("Khiron" or the "Company"), announces that its wholly owned subsidiary ZereniaTM Colombia has closed an unsecured revolving credit facility of CAD 580,0001 with a private financing company in Colombia.The 12-month revolving credit facility became effective on February 10, 2023, and was provided by a Colombian private financing company. The Company was granted this working capital credit line after having established a relationship...

    2023-02-14 8:00 AM EST